Crown CRO is proud to be part of the CoroPrevention Clinical Trial – a unique opportunity to evaluate personalized prevention in CHD.
Coronary Heart Disease (CHD) affects both men and women and remains the leading cause of premature death globally. Cardiovascular diseases are a huge burden especially on the EU economy, costing the EU more than 200 billion euros annually. The aging population and the number of people affected by CHD increase in the EU. Thus, novel […]Read more